PL2799441T3 - Sposoby konwergentnej syntezy pochodnych kalicheamycyny - Google Patents

Sposoby konwergentnej syntezy pochodnych kalicheamycyny

Info

Publication number
PL2799441T3
PL2799441T3 PL14171872T PL14171872T PL2799441T3 PL 2799441 T3 PL2799441 T3 PL 2799441T3 PL 14171872 T PL14171872 T PL 14171872T PL 14171872 T PL14171872 T PL 14171872T PL 2799441 T3 PL2799441 T3 PL 2799441T3
Authority
PL
Poland
Prior art keywords
processes
convergent synthesis
calicheamicin derivatives
calicheamicin
derivatives
Prior art date
Application number
PL14171872T
Other languages
English (en)
Inventor
Justin Keith Moran
Jianxin Gu
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38437933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2799441(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL2799441T3 publication Critical patent/PL2799441T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14171872T 2006-02-21 2007-02-16 Sposoby konwergentnej syntezy pochodnych kalicheamycyny PL2799441T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77537006P 2006-02-21 2006-02-21
EP07751087.3A EP1987048B1 (en) 2006-02-21 2007-02-16 Processes for the convergent synthesis of calicheamicin derivatives
EP14171872.6A EP2799441B1 (en) 2006-02-21 2007-02-16 Processes for the convergent synthesis of calicheamicin derivatives

Publications (1)

Publication Number Publication Date
PL2799441T3 true PL2799441T3 (pl) 2018-08-31

Family

ID=38437933

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14171872T PL2799441T3 (pl) 2006-02-21 2007-02-16 Sposoby konwergentnej syntezy pochodnych kalicheamycyny
PL07751087T PL1987048T3 (pl) 2006-02-21 2007-02-16 Sposoby konwergentnej syntezy pochodnych kalicheamycyny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07751087T PL1987048T3 (pl) 2006-02-21 2007-02-16 Sposoby konwergentnej syntezy pochodnych kalicheamycyny

Country Status (31)

Country Link
US (6) US20070197455A1 (pl)
EP (2) EP2799441B1 (pl)
JP (4) JP5179383B2 (pl)
KR (1) KR101454489B1 (pl)
CN (1) CN101389639B (pl)
AR (1) AR059592A1 (pl)
AU (1) AU2007217795B2 (pl)
BR (1) BRPI0708149B1 (pl)
CA (1) CA2642194C (pl)
CL (1) CL2009001487A1 (pl)
CR (1) CR10230A (pl)
CY (1) CY1120206T1 (pl)
DK (2) DK2799441T3 (pl)
EC (1) ECSP088691A (pl)
ES (2) ES2527107T3 (pl)
GT (1) GT200800161A (pl)
HU (1) HUE037880T2 (pl)
IL (1) IL193343A (pl)
MX (1) MX2008010768A (pl)
NO (1) NO20083698L (pl)
PE (1) PE20071229A1 (pl)
PL (2) PL2799441T3 (pl)
PT (2) PT2799441T (pl)
RU (1) RU2436790C2 (pl)
SG (1) SG170013A1 (pl)
SI (2) SI2799441T1 (pl)
SV (1) SV2009003002A (pl)
TR (1) TR201808220T4 (pl)
TW (1) TW200806685A (pl)
WO (1) WO2007098124A2 (pl)
ZA (1) ZA200807196B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200806685A (en) * 2006-02-21 2008-02-01 Wyeth Corp Processes for the convergent synthesis of calicheamicin derivatives
US20120316106A1 (en) 2009-12-29 2012-12-13 Yeda Research And Development Co. Ltd. Synergistic antibiotic combinations and derivatives
DK2885007T3 (en) * 2012-08-16 2018-12-03 Pfizer Methods for glycoconjugation and compositions
CN108047287B (zh) * 2013-11-04 2021-04-27 辉瑞大药厂 用于合成加利车霉素衍生物的中间体和方法
JP2016540826A (ja) 2013-11-04 2016-12-28 ファイザー・インク 抗efna4抗体−薬物コンジュゲート
RU2708075C2 (ru) 2014-04-30 2019-12-04 Пфайзер Инк. Конъюгаты анти-ртк7 антитело-лекарственное средство
US10464442B2 (en) * 2016-10-11 2019-11-05 Honda Motor Co., Ltd. Non-contact power supply system and power transmission apparatus, and designing method and installing method of power transmission apparatus
WO2019018647A1 (en) 2017-07-20 2019-01-24 Pfizer Inc. ANTI-GD3 ANTIBODIES AND CONJUGATES ANTIBODY-MEDICATION
US11576981B2 (en) 2017-12-06 2023-02-14 Ontario Institute For Cancer Research (Oicr) Acyl hydrazone linkers, methods and uses thereof
WO2019119141A1 (en) 2017-12-22 2019-06-27 Ontario Institute For Cancer Research (Oicr) Heterocyclic acyl hydrazone linkers, methods and uses thereof
CN111647865B (zh) * 2020-08-06 2020-11-24 北京卓立汉光仪器有限公司 溅射镀膜方法、装置及系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970198A (en) 1985-10-17 1990-11-13 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5108912A (en) * 1987-01-30 1992-04-28 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
US5770701A (en) * 1987-10-30 1998-06-23 American Cyanamid Company Process for preparing targeted forms of methyltrithio antitumor agents
US5053394A (en) 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
NZ509273A (en) * 1998-07-16 2003-05-30 Res Dev Foundation DNA-cleaving antitumor agents containing a benzimidazole derivative
TW200806685A (en) * 2006-02-21 2008-02-01 Wyeth Corp Processes for the convergent synthesis of calicheamicin derivatives

Also Published As

Publication number Publication date
TW200806685A (en) 2008-02-01
SI1987048T1 (sl) 2015-01-30
CR10230A (es) 2008-10-03
CN101389639B (zh) 2012-07-18
US20090312530A1 (en) 2009-12-17
CY1120206T1 (el) 2018-12-12
CN101389639A (zh) 2009-03-18
JP2016011316A (ja) 2016-01-21
WO2007098124A3 (en) 2007-12-27
ES2527107T3 (es) 2015-01-20
EP1987048A2 (en) 2008-11-05
US20150315138A1 (en) 2015-11-05
BRPI0708149B1 (pt) 2022-01-25
DK2799441T3 (en) 2018-05-28
US8546549B2 (en) 2013-10-01
JP2014196352A (ja) 2014-10-16
EP2799441A1 (en) 2014-11-05
KR101454489B1 (ko) 2014-10-27
MX2008010768A (es) 2008-11-28
SV2009003002A (es) 2009-01-28
JP2013040213A (ja) 2013-02-28
US10343989B2 (en) 2019-07-09
PT1987048E (pt) 2015-01-14
US9802890B2 (en) 2017-10-31
KR20080094925A (ko) 2008-10-27
RU2008132777A (ru) 2010-03-27
US20130018179A1 (en) 2013-01-17
ZA200807196B (en) 2009-05-27
CA2642194A1 (en) 2007-08-30
SI2799441T1 (en) 2018-07-31
GT200800161A (es) 2009-01-15
HUE037880T2 (hu) 2018-09-28
TR201808220T4 (tr) 2018-07-23
CA2642194C (en) 2015-12-08
IL193343A (en) 2017-03-30
PE20071229A1 (es) 2007-11-30
JP2009527557A (ja) 2009-07-30
HK1203515A1 (en) 2015-10-30
CL2009001487A1 (es) 2009-10-16
AU2007217795B2 (en) 2012-09-13
JP5179383B2 (ja) 2013-04-10
AU2007217795A1 (en) 2007-08-30
RU2436790C2 (ru) 2011-12-20
DK1987048T3 (en) 2014-12-15
US20180016228A1 (en) 2018-01-18
EP2799441B1 (en) 2018-04-18
BRPI0708149A2 (pt) 2011-05-17
IL193343A0 (en) 2009-08-03
ECSP088691A (es) 2008-09-29
US20140081010A1 (en) 2014-03-20
SG170013A1 (en) 2011-04-29
AR059592A1 (es) 2008-04-16
PL1987048T3 (pl) 2015-03-31
PT2799441T (pt) 2018-05-29
EP1987048B1 (en) 2014-11-19
NO20083698L (no) 2008-11-12
ES2670709T3 (es) 2018-05-31
US20070197455A1 (en) 2007-08-23
US8273862B2 (en) 2012-09-25
WO2007098124A2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
ZA200807196B (en) Processes for the convergent synthesis of calicheamicin derivatives
IL183938A0 (en) Amino - imidazolones for the inhibition of ?? - becretase
PT2032709T (pt) Sistema para a produção de metano a partir de co2
EG25867A (en) Enhanced process for the synthesis of urea
GB0702854D0 (en) Method for the synthesis of sucrose-6-esters
ZA200903889B (en) Process for the synthesis of moxifloxacin hydrochloride
PL2097841T3 (pl) Synteza wielomianów
IL201245A0 (en) An improved process for the synthesis of solifenacin
IL196403A0 (en) Processes for the synthesis of o-desmethylvenlafaxine
EP2019118A4 (en) METHOD FOR SYNTHETIZING THYMOSINS
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
ZA200903161B (en) Process for hydrocarbon synthesis
IL196269A0 (en) Tridesmethylvenlafaxine and processes for the synthesis of o-desmethylvenlafaxine
IL184800A0 (en) Method for the production of losartan
PL2137202T3 (pl) Sposób syntezy IB-MECA
GB0614245D0 (en) Synthesis process
GB2459413B (en) Methods for the synthesis of perfluoroparacyclophane
IL194330A0 (en) Processes for the synthesis of 3-isobutylglutaric acid
PL380561A1 (pl) Sposób otrzymywania pochodnych antracyklin
EP2170902A4 (en) IMPROVED METHOD FOR SYNTHESIS OF OLANZAPINE
GB0618703D0 (en) Synthesis of leikotriene compounds
GB0614246D0 (en) Synthesis process
PL2076521T3 (pl) Sposób otrzymywania sililopodstawionych 1,2 alkinów
GB0704205D0 (en) Emotional spech synthesis
GB0609666D0 (en) Synthesis